secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mirum Pharmaceuticals, Inc. (MIRM)
CIK:        0001759425
Form:       8-K
Filed at:   2024-01-16T23:59:59+00:00
Accession:  0001193125-24-008569
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Mirum Pharmaceuticals promotes Peter Radovich to President effective Jan 16, 2024
--------------------------------------------------------------------------------

- Peter Radovich promoted to President, effective Jan 16, 2024, while continuing as COO.
- Christopher Peetz remains CEO; Radovich had served as COO since April 2020.
- Radovich previously held senior roles at Global Blood Therapeutics and Onyx Pharmaceuticals.
- Promotion expands Radovich's responsibilities but no change in CEO role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759425/000119312524008569/0001193125-24-008569-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759425/000119312524008569/d723597d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-008569

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer